STLT just hit the wires with more news, this time it is a French Gov approval to enter stage 2 of a phase 1 cancer drug trial. Tomorrow could be a huge rally back to $2 from $1/share
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.